Size Matters: The CAG Repeat Length of the Androgen Receptor Gene, Testosterone, and Male Adolescent Depression Severity.

CAG repeat length adolescents androgen receptor depression testosterone

Journal

Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006

Informations de publication

Date de publication:
2021
Historique:
received: 29 06 2021
accepted: 23 09 2021
entrez: 8 11 2021
pubmed: 9 11 2021
medline: 9 11 2021
Statut: epublish

Résumé

There is a distinct increase in the prevalence of depression with the onset of puberty. The role of peripubertal testosterone levels in boys in this context is insufficiently understood and may be modulated by a functional polymorphism of the androgen receptor gene (AR), a variable number of CAG repeats. Moreover, there is preliminary evidence that the relationship between testosterone, CAG repeat length, and the severity of depressive symptoms may differ between subclinical and overt depression, but this has neither been studied in a clinical sample of adolescents with depression nor compared between subclinical and overt depression in an adequately powered study. To investigate the relationship between free testosterone, CAG repeat length of the AR, depression status (subclinical vs. overt), and the severity of depressive symptoms, 118 boys treated as in- or daycare patients at a single psychiatric hospital were studied. Of these, 73 boys had at least mild depressive symptoms according to the Beck Depression Inventory-II (BDI-II > 13). Higher-order moderation analysis in the multiple regression framework revealed a constant relationship between free testosterone and depression severity irrespective of the number of CAG repeats in adolescents with a BDI-II score ≤ 13. In adolescents with a BDI-II score > 13, however, there was a significant negative relationship between free testosterone and BDI-II score in patients with <19 CAG repeats and a significant positive relationship regarding free testosterone and BDI-II score in those with more than 28 CAG repeats, even when considering important covariates. These results suggest that the effects of testosterone on mood in male adolescents with depression depend on the genetic make-up of the AR as well as on depression status. This complex relationship should be considered by future studies addressing mental health issues against an endocrine background and may, moreover, contribute to tailored treatment concepts in psychiatric medicine, especially in adults.

Identifiants

pubmed: 34744823
doi: 10.3389/fpsyt.2021.732759
pmc: PMC8564040
doi:

Types de publication

Journal Article

Langues

eng

Pagination

732759

Informations de copyright

Copyright © 2021 Hirtz, Libuda, Hinney, Föcker, Bühlmeier, Holterhus, Kulle, Kiewert, Hebebrand and Grasemann.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Horm Res Paediatr. 2013;79(1):22-31
pubmed: 23328487
Psychiatry Res. 2019 Oct;280:112503
pubmed: 31446215
Clin Psychol Sci. 2019 May;7(3):411-429
pubmed: 31179165
BMC Med. 2017 Apr 13;15(1):80
pubmed: 28403846
J Clin Endocrinol Metab. 2009 Jan;94(1):277-84
pubmed: 18840639
Epilepsy Behav. 2006 Feb;8(1):102-14
pubmed: 16356779
J Mol Med (Berl). 2006 Nov;84(11):919-31
pubmed: 16932916
Depress Anxiety. 2014 May;31(5):374-8
pubmed: 24677535
Assessment. 2002 Jun;9(2):164-70
pubmed: 12066831
Mol Hum Reprod. 2010 Mar;16(3):153-7
pubmed: 19884136
J Clin Endocrinol Metab. 1999 Oct;84(10):3666-72
pubmed: 10523012
J Surg Res. 2009 Jun 1;154(1):38-44
pubmed: 19062046
J Res Adolesc. 2019 Mar;29(1):32-53
pubmed: 30869842
J Clin Endocrinol Metab. 2002 Aug;87(8):3893-901
pubmed: 12161529
Psychoneuroendocrinology. 2013 Oct;38(10):2083-90
pubmed: 23602133
J Am Acad Child Adolesc Psychiatry. 1997 Jul;36(7):980-8
pubmed: 9204677
Eur J Endocrinol. 2010 Aug;163(2):319-28
pubmed: 20479013
J Huntingtons Dis. 2019;8(4):443-448
pubmed: 31561381
J Neurosci. 2008 Sep 17;28(38):9519-24
pubmed: 18799683
J Abnorm Psychol. 2014 Nov;123(4):725-36
pubmed: 25314262
Lancet Diabetes Endocrinol. 2014 Jul;2(7):581-92
pubmed: 24731664
Z Kinder Jugendpsychiatr Psychother. 2014 Jul;42(4):243-52
pubmed: 25005902
J Neurol Sci. 1996 Jan;135(1):43-50
pubmed: 8926495
Biol Psychiatry. 2003 Nov 1;54(9):943-6
pubmed: 14573323
Lancet. 2012 Mar 17;379(9820):1056-67
pubmed: 22305766
Nucleic Acids Res. 1994 Aug 11;22(15):3181-6
pubmed: 8065934
PLoS One. 2020 Feb 21;15(2):e0229345
pubmed: 32084211
Biol Psychiatry. 2001 Sep 1;50(5):371-6
pubmed: 11543741
Psychoneuroendocrinology. 2018 Jan;87:196-203
pubmed: 29107881
Mol Psychiatry. 2020 Feb;25(2):243-253
pubmed: 31676814
J Clin Endocrinol Metab. 2010 May;95(5):2399-409
pubmed: 20200336
Psychoneuroendocrinology. 2009 Oct;34(9):1272-83
pubmed: 19406581
Sex Med Rev. 2018 Jan;6(1):69-76
pubmed: 29128270
Hormones (Athens). 2013 Oct-Dec;12(4):567-77
pubmed: 24457405
Eur J Nutr. 2020 Dec;59(8):3415-3424
pubmed: 32108263
Dev Cogn Neurosci. 2017 Jun;25:12-28
pubmed: 28077245
Int J Biol Markers. 2006 Apr-Jun;21(2):96-105
pubmed: 16847812
Andrology. 2017 May;5(3):495-504
pubmed: 28334513
Nat Neurosci. 2019 Mar;22(3):343-352
pubmed: 30718901
Front Neuroendocrinol. 2017 Oct;47:47-65
pubmed: 28705582
Horm Behav. 2017 Jun;92:93-102
pubmed: 27702564
Am J Hum Genet. 1999 Oct;65(4):966-73
pubmed: 10486315
JAMA Psychiatry. 2019 Jan 1;76(1):31-40
pubmed: 30427999
J Adolesc Health. 2014 Sep;55(3):315-22
pubmed: 25151053
Horm Behav. 2010 Jan;57(1):63-75
pubmed: 19703457
Psychoneuroendocrinology. 2007 Sep-Nov;32(8-10):951-8
pubmed: 17659846

Auteurs

Raphael Hirtz (R)

Division of Pediatric Endocrinology and Diabetology, Department of Pediatrics II, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Lars Libuda (L)

Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Faculty of Natural Sciences, Institute of Nutrition, Consumption and Health, University Paderborn, Paderborn, Germany.

Anke Hinney (A)

Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Manuel Föcker (M)

Department of Child and Adolescent Psychiatry, University Hospital Münster, Münster, Germany.

Judith Bühlmeier (J)

Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Paul-Martin Holterhus (PM)

Department of Paediatrics I, Paediatric Endocrinology and Diabetes, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Christian-Albrechts-University, Kiel, Germany.

Alexandra Kulle (A)

Department of Paediatrics I, Paediatric Endocrinology and Diabetes, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Christian-Albrechts-University, Kiel, Germany.

Cordula Kiewert (C)

Division of Pediatric Endocrinology and Diabetology, Department of Pediatrics II, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Johannes Hebebrand (J)

Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Corinna Grasemann (C)

Department of Pediatrics, St. Josef-Hospital, Center for Rare Diseases (CeSER), Ruhr-University Bochum, Bochum, Germany.

Classifications MeSH